Scheltens P - Search Results

1

Preclinical AD predicts decline in memory and executive functions in subjective complaints.

van Harten AC, Smits LL, Teunissen CE, Visser PJ, Koene T, Blankenstein MA, Scheltens P, van der Flier WM. van Harten AC, et al. Among authors: scheltens p. Neurology. 2013 Oct 15;81(16):1409-16. doi: 10.1212/WNL.0b013e3182a8418b. Epub 2013 Sep 18. Neurology. 2013. PMID: 24049134

2

White matter lesions and hippocampal atrophy in Alzheimer's disease.

de Leeuw FE, Barkhof F, Scheltens P. de Leeuw FE, et al. Among authors: scheltens p. Neurology. 2004 Jan 27;62(2):310-2. doi: 10.1212/01.wnl.0000103289.03648.ad. Neurology. 2004. PMID: 14745078

3

Biomarkers for Alzheimer's disease. Which way to go?

Teunissen CE, Scheltens P. Teunissen CE, et al. Among authors: scheltens p. Neurobiol Aging. 2004 Jul;25(6):695-6. doi: 10.1016/j.neurobiolaging.2003.08.013. Neurobiol Aging. 2004. PMID: 15165690 No abstract available.

4

Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment.

Korf ES, Wahlund LO, Visser PJ, Scheltens P. Korf ES, et al. Among authors: scheltens p. Neurology. 2004 Jul 13;63(1):94-100. doi: 10.1212/01.wnl.0000133114.92694.93. Neurology. 2004. PMID: 15249617

5

Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice.

Schoonenboom NS, Mulder C, Vanderstichele H, Van Elk EJ, Kok A, Van Kamp GJ, Scheltens P, Blankenstein MA. Schoonenboom NS, et al. Among authors: scheltens p. Clin Chem. 2005 Jan;51(1):189-95. doi: 10.1373/clinchem.2004.039735. Epub 2004 Nov 11. Clin Chem. 2005. PMID: 15539465

6

Medial temporal lobe atrophy and APOE genotype do not predict cognitive improvement upon treatment with rivastigmine in Alzheimer's disease patients.

Visser PJ, Scheltens P, Pelgrim E, Verhey FR; Dutch ENA-NL-01 Study Group. Visser PJ, et al. Among authors: scheltens p. Dement Geriatr Cogn Disord. 2005;19(2-3):126-33. doi: 10.1159/000082883. Epub 2004 Dec 23. Dement Geriatr Cogn Disord. 2005. PMID: 15627759

7

Differences and similarities between two frequently used assays for amyloid beta 42 in cerebrospinal fluid.

Schoonenboom NS, Mulder C, Vanderstichele H, Pijnenburg YA, Van Kamp GJ, Scheltens P, Mehta PD, Blankenstein MA. Schoonenboom NS, et al. Among authors: scheltens p. Clin Chem. 2005 Jun;51(6):1057-60. doi: 10.1373/clinchem.2005.048629. Epub 2005 Apr 21. Clin Chem. 2005. PMID: 15845801 No abstract available.

8

A 24-year follow-up of body mass index and cerebral atrophy.

de Leeuw FE, van der Flier WM, Scheltens P. de Leeuw FE, et al. Among authors: scheltens p. Neurology. 2005 Jun 14;64(11):1990-1; author reply 1990-1. doi: 10.1212/wnl.64.11.1990. Neurology. 2005. PMID: 15955971 No abstract available.

9

Amyloid beta 38, 40, and 42 species in cerebrospinal fluid: more of the same?

Schoonenboom NS, Mulder C, Van Kamp GJ, Mehta SP, Scheltens P, Blankenstein MA, Mehta PD. Schoonenboom NS, et al. Among authors: scheltens p. Ann Neurol. 2005 Jul;58(1):139-42. doi: 10.1002/ana.20508. Ann Neurol. 2005. PMID: 15984010

10

Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study.

van der Flier WM, van Straaten EC, Barkhof F, Verdelho A, Madureira S, Pantoni L, Inzitari D, Erkinjuntti T, Crisby M, Waldemar G, Schmidt R, Fazekas F, Scheltens P. van der Flier WM, et al. Among authors: scheltens p. Stroke. 2005 Oct;36(10):2116-20. doi: 10.1161/01.STR.0000179092.59909.42. Epub 2005 Sep 1. Stroke. 2005. PMID: 16141425 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,267 results

Search Page

Filters